The Identification of a Calmodulin-Binding Domain within the Cytoplasmic Tail of Angiotensin-Converting Enzyme-2

被引:24
|
作者
Lai, Zon W. [1 ]
Lew, Rebecca A. [1 ]
Yarski, Michael A. [3 ]
Mu, Fi-Tjen [2 ]
Andrews, Robert K. [2 ]
Smith, A. Ian [1 ]
机构
[1] Monash Univ, Dept Biochem & Mol Biol, Peptide Biol Lab, Clayton, Vic 3800, Australia
[2] Monash Univ, Cardiovasc Biol Lab, Dept Immunol Alfred Med Res & Educ Precinct, Clayton, Vic 3800, Australia
[3] Baker Heart Res Inst, Epigenet Human Hlth & Dis Lab, Melbourne, Vic 3004, Australia
关键词
ANGIOTENSIN-CONVERTING-ENZYME-2; ACE2; CALCIUM-CHANNELS; GLYCOPROTEIN-VI; UP-REGULATION; CARBOXYPEPTIDASE; HOMOLOG; CELLS; RECOGNITION; EXPRESSION; LIVER;
D O I
10.1210/en.2008-1274
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Angiotensin-converting enzyme (ACE)-2 is a homolog of the well-characterized plasma membrane-bound angiotensin-converting enzyme. ACE2 is thought to play a critical role in regulating heart function, and in 2003, ACE2 was identified as a functional receptor for severe acute respiratory syndrome coronavirus. We have recently shown that like ACE, ACE2 undergoes ectodomain shedding and that this shedding event is up-regulated by phorbol esters. In the present study, we used gel shift assays to demonstrate that calmodulin, an intracellular calcium-binding protein implicated in the regulation of other ectodomain shedding events, binds a 16-amino acid synthetic peptide corresponding to residues 762-777 within the cytoplasmic domain of human ACE2, forming a calcium-dependent calmodulin-peptide complex. Furthermore, we have demonstrated that ACE2 expressed in Chinese hamster ovary cells specifically binds to glutathione-S-transferase-calmodulin, but not glutathione-S-transferase alone, in pull-down assays using cell lysates. Finally, to investigate whether calmodulin has any effect on ACE2 ectodomain shedding in cells that endogenously express the enzyme, cells from a human liver cell line (Huh-7) expressing ACE2 were incubated with calmodulin-specific inhibitors, trifluoperazine and calmidazolium. Both trifluoperazine (25 mu mol/liter) and calmidazolium, (25 mu mol/liter) significantly increased the release of ACE2 into the medium (44.1 +/- 10.8%, P < 0.05, Student's t test; unpaired, two-tailed, and 51.1 +/- 7.4% P < 0.05, one-way ANOVA, respectively;), as analyzed by an ACE2-specific quenched fluorescence substrate assay. We also show that the calmodulin-specific inhibitor-stimulated shedding of ACE2 is independent from phorbol ester-induced shedding. In summary, we have demonstrated that calmodulin is able to bind ACE2 and suggest that the ACE2 ectodomain shedding and/or sheddase(s) activation regulated by calmodulin is independent from the phorbol ester-induced shedding. (Endocrinology 150: 2376-2381, 2009)
引用
收藏
页码:2376 / 2381
页数:6
相关论文
共 50 条
  • [41] Vascular Angiotensin-Converting Enzyme 2 Lord of the Ring?
    Batlle, Daniel
    Wysocki, Jan
    Khan, Mirza S.
    CIRCULATION RESEARCH, 2010, 107 (07) : 822 - 824
  • [42] SCREENING OF ANGIOTENSIN-CONVERTING ENZYME-2 AND FURIN INHIBITORS AS DRUG LEADS AGAINST SARS-COV2
    Bency, Jesvin
    APPLIED BIOLOGICAL RESEARCH, 2023, 25 (03) : 253 - 260
  • [43] Angiotensin-Converting Enzyme 2-Independent Action of Presumed Angiotensin-Converting Enzyme 2 Activators Studies In Vivo, Ex Vivo, and In Vitro
    Haber, Philipp K.
    Ye, Minghao
    Wysocki, Jan
    Maier, Christoph
    Haque, Syed K.
    Batlle, Daniel
    HYPERTENSION, 2014, 63 (04) : 774 - 782
  • [44] Differential expression of angiotensin-converting enzyme-2 in human paranasal sinus mucosa in patients with chronic rhinosinusitis
    Kawasumi, T.
    Takeno, S.
    Nishimura, M.
    Ishino, T.
    Ueda, T.
    Hamamoto, T.
    Takemoto, K.
    Horibe, Y.
    JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2021, 135 (09) : 773 - 778
  • [45] Dual deficiency of angiotensin-converting enzyme-2 and Mas receptor enhances angiotensin II-induced hypertension and hypertensive nephropathy
    Ni, Jun
    Yang, Fuye
    Huang, Xiao-Ru
    Meng, Jinxiu
    Chen, Jiaoyi
    Bader, Michael
    Penninger, Josef M.
    Fung, Erik
    Yu, Xue-Qing
    Lan, Hui-Yao
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2020, 24 (22) : 13093 - 13103
  • [46] Angiotensin-converting enzyme 2 and renal disease
    Williams, Vanessa R.
    Scholey, James W.
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2018, 27 (01) : 35 - 41
  • [47] Deletion of Angiotensin-Converting Enzyme-2 Promotes Hypertensive Nephropathy by Targeting Smad7 for Ubiquitin Degradation
    Liu, Zhen
    Huang, Xiao-Ru
    Chen, Hai-Yong
    Fung, Erik
    Liu, Jian
    Lan, Hui-Yao
    HYPERTENSION, 2017, 70 (04) : 822 - +
  • [48] Antiglaucomatous Effects of the Activation of Intrinsic Angiotensin-Converting Enzyme 2
    Foureaux, Giselle
    Nogueira, Jose C.
    Nogueira, Barbara S.
    Fulgencio, Gustavo O.
    Menezes, Gustavo B.
    Fernandes, Simone O. A.
    Cardoso, Valbert N.
    Fernandes, Renata S.
    Oliveira, Gabriel P.
    Franca, Jucara R.
    Faraco, Andre A. G.
    Raizada, Mohan K.
    Ferreira, Anderson J.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (06) : 4296 - 4306
  • [49] Binding of SARS-CoV-2 and angiotensin-converting enzyme 2: clinical implications
    Murray, Eleanor
    Tomaszewski, Maciej
    Guzik, Tomasz J.
    CARDIOVASCULAR RESEARCH, 2020, 116 (07) : E87 - E89
  • [50] Angiotensin converting enzyme-2 as therapeutic target in COVID-19
    Roshanravan, Neda
    Ghaffari, Samad
    Hedayati, Mehdi
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2020, 14 (04) : 637 - 639